Dr. Bradley S. Peterson, MD

Claim this profile
Studies Social Anxiety Disorder
Studies Anxiety Disorders
3 reported clinical trials
3 drugs studied

Clinical Trials Bradley S. Peterson, MD is currently running

Image of trial facility.

Brief Exposure Therapy

for PTSD

The goal of this clinical trial is to develop a new behavioral treatment for U.S. combat veterans with post-traumatic stress disorder (PTSD), very brief exposure to combat-related stimuli. The main questions it aims to answer are: 1. How does Very Brief Exposure (combat images and control everyday images) and Visible Exposure to combat stimuli affect brain activity and subjective fear ratings? 2. To what extent are participants aware of the stimuli presented and tolerating the exposures? All participants will view both very brief exposure and visible exposure to combat stimuli in the functional magnetic brain imaging (fMRI) scan. They will provide ratings of fear, awareness, and tolerability. Researchers will compare U.S. combat veterans with PTSD and healthy controls to confirm differences in brain region activation and ratings.

Recruiting

1 award

N/A

Image of trial facility.

Very Brief Exposure

for Social Anxiety Disorder

The goal of this clinical trial is to identify the circuit activations by very brief exposure (VBE) among youth with social anxiety disorder (SAD) in order to develop a novel intervention for those with SAD. The secondary objectives of this study are to measure the effect of VBE on subjective fear ratings, and participants' awareness and tolerance of the exposure stimuli. * The primary outcome of this study is the mean activation of frontostriatal and prefrontal brain regions to facial stimuli, as measured by Blood Oxygen Level Dependent (BOLD) response, in 4 regions of interest during the magnetic resonance imaging (MRI). * Another primary outcome of the study is to identify networks of regions subserving emotion regulation and attention, as measured by BOLD response of corresponding brain regions. Secondary Outcomes -The secondary outcome of this study is the fear induced by exposure to facial expression stimuli as measured by a 4-point fear scale during the functional magnetic resonance imaging (fMRI) after each block of 10 facial expression stimuli trials. Participants will participate in an interview where they will answer questions both inside and outside of the MRI scan. Participants will be asked to rate on a scale the imagines they see while undergoing MRI scan.

Recruiting

1 award

N/A

1 criteria

More about Bradley S. Peterson, MD

Clinical Trial Related

1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Bradley S. Peterson, MD has experience with

  • Very Brief Exposure
  • Cognitive Behavioral Therapy (CBT)
  • Fluoxetine

Breakdown of trials Bradley S. Peterson, MD has run

Post-Traumatic Stress Disorder

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Bradley S. Peterson, MD specialize in?

Is Bradley S. Peterson, MD currently recruiting for clinical trials?

Are there any treatments that Bradley S. Peterson, MD has studied deeply?

What is the best way to schedule an appointment with Bradley S. Peterson, MD?

Is there any support for travel costs?